Alexander’s Library

The search for the elixir of youth — what the record says, and how strongly. Double-click any word for an instant dictionary or scientific synopsis.

Library / Natural & Life Sciences / Medicine, Health & Longevity / Reproductive Medicine & Human Fertility / Ovarian Reserve & Oocyte Cryopreservation

Cumulative Live Birth Rate and Drop-Out Attrition

Mathematical and clinical modelling of cumulative live birth outcomes comparing accelerated back-to-back accumulation versus time-lagged treatment trajectories.

67 sources ↓Last researched 2026-10-20

Optimizing the Path to Live Birth in Advanced Maternal Age

Navigating Cumulative Success Rates and Treatment Attrition in the +40s Demographic

Synopsis · Executive Overview

For women over 40, the goal of IVF is increasingly shifting from per-cycle success to the maximization of the Cumulative Live Birth Rate (CLBR). Success in this age demographic is hindered by biological realities—primarily oocyte aneuploidy—and psychological stressors that drive treatment drop-out. While accelerated protocols like DuoStim show promise in shortening the timeline, patients must balance these technical interventions against the reality of attrition and the high emotional toll of repeated cycles.

Section I · The Mathematics of Success

Oocyte Yield and CLBR

The cumulative live birth rate is essentially a function of oocyte quantity and competence. Clinical evidence consistently shows that higher retrieval numbers (up to 15-20) correlate with improved CLBR, with each mature MII oocyte providing a measurable increment of approximately 5.4% in the probability of achieving a live birth. However, this linearity plateaus as age increases, as the rate of aneuploidy in embryos rises sharply, necessitating more cycles to find a euploid blastocyst.

Standardizing success is the primary debate in the field. Per-cycle success rates are often misleading; CLBR provides a more transparent view, provided it accounts for the entire reproductive trajectory, including frozen embryo transfers and the time required to exhaust the available cohort.

Section II · Accelerated Trajectories

Breaking the Time-Lag

To mitigate the risk of drop-out, clinicians have explored 'accelerated' treatment cycles. The DuoStim protocol, which utilizes two stimulation phases in one cycle, has emerged as a way to shorten the path to pregnancy for women with low ovarian reserve. While initial debates questioned if this increased the total oocyte count, recent evidence suggests it is highly effective at reducing the calendar time between retrievals, thereby keeping patients engaged before attrition sets in.

Alternative protocols like PPOS have also gained traction, offering a lower-cost, simpler hormonal environment compared to traditional antagonist protocols, further reducing the 'barrier to entry' for subsequent cycles.

Evidence Hierarchy (Graded Claims)

  • T1Synthesis of trials
    3 (19%)
  • T2Randomised trial
    1 (6%)
  • T3Observational, large
    8 (50%)
  • T4Observational, small or case-based
    2 (13%)
  • T5Preclinical or mechanistic
    0 (0%)
  • T6Opinion, news or unverified
    2 (13%)
11 settled4 debated1 contested / frontier

Study Designs in Indexed Literature

  • Meta-analyses, Systematic Reviews & Guidelines12 (18%)
  • Randomised Controlled Trials (RCTs)8 (12%)
  • Prospective Cohorts & Clinical Registries21 (31%)
  • Observational & Clinical Case Series4 (6%)
  • Preclinical, Cellular & Computational Models3 (4%)
  • Primary Literature & Archive Records19 (28%)

Publication Timeline Velocity

Fig. 1 — Field Evidence Architecture & Publication Trajectory. Distribution of methodological study designs (67 indexed publications) and 16 extracted claims graded from T1 (meta-analyses and guidelines) to T6.

Epistemic Verdict Distribution Across Evaluated Levers & Mechanisms (3)

Supported2 levers (67%)
Trial only1 lever (33%)
Fig. 2 — Intervention & Mechanism Epistemic Calibration. Proportion of evaluated clinical interventions or theoretical models supported by replicated trials versus subgroup-specific or experimental evidence.
Primary Citations & Landmark Studies

Key Studies Anchoring This Monograph

Synthesis & Conclusions

State of the Field Conclusions

The evidence suggests that managing IVF for women over 40 requires a strategic pivot from single-cycle optimization to a longitudinal 'accumulation' approach. By focusing on total CLBR, utilizing efficient protocols like DuoStim, and addressing the patient's psychological estimation of success, clinics can improve retention and potentially improve outcomes. Future efforts must focus on reducing the high rates of drop-out after failed cycles to ensure that patients do not leave the system prematurely due to misconceptions about their prognosis.

Key Quantitative Takeaways

  • Each additional mature MII oocyte increases live birth probability by roughly 5.4% (T3).
  • DuoStim effectively shortens the time to live birth in women with low ovarian reserve (T3).
  • Patient overestimation of success (often exceeding 80% when reality is lower) is a primary driver of treatment drop-out (T4).
  • Smoking cessation and weight management remain critical, as they can degrade live birth outcomes equivalent to over a decade of biological aging (T3).
5.4%

Increase in odds of live birth per additional MII oocyte retrieved

Clinical Research 2026

~25%

Percentage of IVF patients who accurately estimate their probability of success within 20%

Reproductive Health Studies 2023

Where each lever applies

A graded decision ledger of interventions across clinical subgroups. Each row names its best landmark evidence, measured effect, clinical reading, and epistemic verdict.

Supported: RCT live-birth gainTargeted: specific subgroupGuideline: clinical consensusWeak: inconsistent/unproven gainNot supported: RCTs show no gainTrial: human trial in progressLab: preclinical / cell dish

Ovarian Stimulation

Lever & MechanismBest Landmark EvidenceMeasured Effect & Clinical ReadingVerdict
DuoStim (Dual Stimulation)

Two stimulation phases within one menstrual cycle to harvest more oocytes.

Clinical trials on poor responders (2026, 2025)

Effect: Shortens time to live birth vs conventional spaced cycles.

Clinical reading: Effective for maximizing yield in patients with low ovarian reserve.

Supported
Minimal Stimulation (MS-IVF)

Lower doses of FSH/LH to recruit fewer, potentially higher-quality oocytes.

Comparative studies 2022

Effect: Comparable pregnancy outcomes to C-IVF.

Clinical reading: Potential cost-saving, but no significant advantage in success rate per cycle.

Trial only

Preparation & Transfer

Lever & MechanismBest Landmark EvidenceMeasured Effect & Clinical ReadingVerdict
Progesterone-primed Ovarian Stimulation (PPOS)

Alternative to GnRH antagonists using progestins.

Meta-analysis (2024, 2021)

Effect: Cost-effective and clinically simpler.

Clinical reading: Useful for cycle accumulation without significant efficacy loss.

Supported

Questions for specialist consultations

High-yield clinical and laboratory inquiries directly derived from the evidence record.

  1. What is our projected cumulative success rate over three cycles given my current AMH and AFC?
  2. Does the potential benefit of a shortened time-to-pregnancy with DuoStim outweigh the potential physical and financial strain compared to standard protocols?
  3. How do we account for the attrition risk in our plan if the first cycle fails?
  4. Are there specific lifestyle modifications that would measurably improve my oocyte quality prior to starting the stimulation protocol?

Queued for next research sweep

Frontier clinical trials, emerging biology, and targeted subgroup outcomes tracked by the autonomous research worker.

  • Large-scale longitudinal studies on the mental health impact of 'back-to-back' accelerated IVF cycles.
  • Evaluation of AI-driven embryo selection tools in reducing the number of cycles required to reach live birth.
  • Cost-benefit analysis of PPOS vs traditional GnRH-antagonist protocols in private vs public healthcare systems.
Historical timeline (5 milestones, 1978–2023)
  1. 1978

    First IVF baby

    Louise Brown was born as the first IVF baby.

  2. 2015

    Consensus Call for CLBR Reporting

    Stakeholders proposed a global consensus on the calculation and interpretation of cumulative live birth rates to include the dimension of time.

  3. 2017

    Standardization of CLBR Definition

    The International Committee for Monitoring Assisted Reproductive Technologies (ICMART) defined CLBR as the number of deliveries from one initiated/aspirated cycle until a live birth or all embryos are exhausted.

  4. 2021

    CLBR Secular Trend

    Registry-level data confirmed a significant 9.3% absolute increase in cumulative live birth rates per aspiration between 2007 and 2017, coinciding with broader adoption of blastocyst culture and vitrification.

  5. 2023

    The BISTIM Study Results

    Publication of one of the first randomized controlled trials comparing DuoStim with conventional spaced antagonist cycles in poor responders.

Evidence by study design (16 findings across T1–T6)

Strongest support first. The bar beside each finding shows its grade.

Synthesis of trials

  1. #1 Advanced maternal age leads to reduced fertility primarily through increased aneuploidy and decreased oocyte competence, which can be partially mitigated by individualized stimulation protocols using AMH or AFC markers.

    Impact of Maternal Age on Oocyte and Embryo Competence. (2018); Individualization of controlled ovarian stimulation in IVF using ova… (2013)

    Aneuploidy is the canonical cause of age-related failure, necessitating personalized dosing to optimize outcomes in older patients.

  2. #2 Cumulative live birth rates (CLBR) in freeze-all IVF cycles increase proportionally with the total number of oocytes retrieved, with 15-20 oocytes identified as the optimal target cohort size.

    Ovarian stimulation for freeze-all IVF cycles: a systematic review (2019)

    The systematic review confirms that maximizing oocyte yield remains the primary driver of cumulative success despite potential retrieval risks.

  3. #3 Evidence for the efficacy of endometrial scratching in improving live birth rates remains contested, with recent meta-analyses providing conflicting results.

    ContestedImpact of Endometrial Scratching on IVF/ICSI Outcomes: A Meta-Analysis (2026); Endometrial scratching prior to IVF; does it help and for whom? A sy… (2018)

    While one meta-analysis indicates a slight benefit in live birth rates, earlier systematic reviews found no significant improvement, suggesting patient-specific efficacy remains unclear.

Randomised trial

  1. #4 Progesterone-primed ovarian stimulation (PPOS) is evaluated as a cost-effective and simpler alternative to GnRH antagonist protocols for oocyte accumulation strategies.

    Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the B… (2024); Oocyte accumulation in low-ovarian reserve women: do or not to do? (2024); Comparison of Cumulative Live Birth Rates Per Aspiration IVF/ICSI Cy… (2021)

    Evidence indicates PPOS provides similar cumulative live birth rates and embryo yields compared to GnRH antagonist protocols, offering reduced complexity.

Observational, large

  1. #5 Cumulative live birth rates (CLBR) are significantly influenced by maternal age, with women ≥ 35 years showing reduced odds of success in ART cycles.

    Exploring determinants of cumulative live birth rates in IVF: insigh… (2026)

    Maternal age is a universally recognized primary driver of biological fertility and IVF success.

  2. #6 Accounting for multiple cycles using cluster-weighted generalized estimating equation models (CWGEE) provides narrower confidence intervals and potentially reduces bias compared to first-cycle only analysis.

    DebatedMethodological approaches to analyzing IVF data with multiple cycles (2018)

    Methodological consensus on how to handle correlated cycle data is currently evolving to improve statistical accuracy.

  3. #7 Double stimulation within a single menstrual cycle (DuoStim) is proposed as a strategy to increase the number of oocytes and embryos obtained in women with poor ovarian reserve or advanced maternal age.

    DebatedOocyte accumulation in low-ovarian reserve women: do or not to do? (2024); The BISTIM study: a randomized controlled trial comparing dual ovari… (2023); O-072 Can preimplantation genetic testing for monogenic conditions r… (2022); Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders (2018); and 1 more

    The strategy aims to maximize egg yield in shorter timeframes for patients with poor prognosis, though its superiority over sequential conventional cycles remains under investigation.

  4. #8 Cumulative live birth rates (CLBR) decrease in women with advanced age, low ovarian reserve, and obesity, which also serve as primary drivers for treatment dropout.

    L26/P-732 A family-building perspective in IVF: the contribution of … (2026); From hope to hesitation: why couples fail to return for infertility … (2025); Impact of Female Obesity on Cumulative Live Birth Rates in the First… (2019)

    Patient attrition at the first consultation or early in the treatment journey is highly correlated with biological factors that negatively impact success.

  5. #9 The DuoStim protocol, involving two ovarian stimulations within a single menstrual cycle, significantly shortens the time to live birth compared to conventional spaced-out stimulation cycles.

    Ten years of DuoStim in time-sensitive poor-prognosis IVF patients: … (2026); DuoStim Shows Comparable Efficacy but Better Efficiency than Two Con… (2025)

    For patients in poor-prognosis categories (e.g., advanced age), minimizing the time-to-conclusion is critical to improving cumulative outcomes and reducing dropout.

  6. #10 Increasing the number of oocytes retrieved is linearly associated with a higher cumulative live birth rate, with each additional MII oocyte increasing the odds of a live birth by approximately 5.4%.

    L26/P-732 A family-building perspective in IVF: the contribution of … (2026)

    Maximizing oocyte yield via flexible multicycle stimulation is essential for optimizing family-building plans.

  7. #11 Lifestyle factors such as smoking significantly degrade live birth outcomes, with smoking effects equivalent to an aging increase of over 10 years.

    Effects of subfertility cause, smoking and body weight on the succes… (2005)

    Large cohort data demonstrates that modifiable lifestyle factors can exacerbate the biological decline associated with maternal age.

  8. #12 A shorter inter-cycle interval between consecutive IVF attempts is associated with higher blastocyst yields and better overall success rates.

    Another round, another chance: oocyte developmental competence and o… (2026)

    Early re-treatment prevents the loss of reproductive potential that occurs as maternal age advances.

Observational, small or case-based

  1. #13 Most women undergoing IVF overestimate their individual chance of success, with only approximately one-fourth accurately estimating their probability within 20%.

    What do women undergoing in vitro fertilization (IVF) understand abo… (2023)

    Patient education and counseling are hindered by a disconnect between perceived and actualized treatment outcomes.

  2. #14 Minimal Ovarian Stimulation IVF (MS-IVF) may be a cost-effective alternative to conventional stimulation (C-IVF) in poor responders, despite comparable pregnancy outcomes.

    DebatedEffectiveness and Cost-effectiveness of Minimal Ovarian Stimulation … (2022)

    Economic modeling allows for trade-offs between reduced medication costs and the lower intensity of minimal stimulation protocols.

Opinion, news or unverified

  1. #15 The assessment of IVF success through Cumulative Live Birth Rate (CLBR) requires standardized inclusion of both fresh and frozen-thawed embryo transfers and must account for the time-lag to utilize all embryos.

    Cumulative live birth rate: time for a consensus? (2015)

    A consensus is needed to properly evaluate 'time-to-pregnancy' as a clinical metric alongside birth rates per cycle.

  2. #16 High patient drop-out rates after a failed IVF treatment may artificially inflate per-period live birth rate estimations.

    DebatedOocyte quantity, as well as oocyte quality, plays a significant role… (2019)

    Attrition bias is a known risk in cumulative success reporting, complicating the interpretation of 'success' in multi-cycle contexts.

Where the record disagrees (3 controversies)
  • Endometrial scratching efficacy is debated due to inconsistent meta-analysis results across different clinical populations.

    Findings #3

  • While DuoStim is proven to shorten total treatment time, its superiority in increasing overall oocyte quantity per cycle compared to conventional approaches is contested.

    Findings #9, #7

  • Minimal Stimulation (MS-IVF) cost-effectiveness versus cumulative success is still under active investigation.

    Findings #14

Node lineage & crossover disciplines

Parent lineage, active node, direct child sub-branches, and associated crossover disciplines across the Tree of Knowledge.

Hierarchy:
Natural & Life SciencesMedicine, Health & LongevityReproductive Medicine & Human FertilityOvarian Reserve & Oocyte CryopreservationCumulative Live Birth Rate and Drop-Out AttritionLeaf node (no child sub-branches yet)
+ Associated nodes:

Branches

No sub-branches yet. Autonomous research agents and the AI tree organiser spawn canonical sub-disciplines here when needed.

AI Tree OrganiserExpand Cumulative Live Birth Rate and Drop-Out Attrition

Branches are never named or placed manually. Ask any scientific question — AI decomposes multi-part inquiries into one, two, three, or more canonical sub-branches and places each under its proper discipline.

Public archive: please keep questions to general scientific concepts (no names, dates of birth, or personal health identifiers). Privacy & copyright.

Auto-classifies taxonomy & cross-links
Primary indexed sources (67)

Primary scientific literature, systematic reviews, and clinical trial registrations indexed for this branch.

  1. Another round, another chance: oocyte developmental competence and outcomes in second IVF attempts—the earlier, the better — Alessandro Ruffa, Danilo Cimadomo, Marilena Taggi et al. Journal of Assisted Reproduction and Genetics, 2026, cohort, 1 citations · DOI: 10.1007/s10815-026-03961-8
  2. Ovarian toxic effects of micro‑ and nanoplastics (Review) — S-R Zhao, Weiting YUAN, Ping Li et al. Experimental and Therapeutic Medicine, 2026, systematic review, 1 citations · DOI: 10.3892/etm.2026.13222
  3. Ten years of DuoStim in time-sensitive poor-prognosis IVF patients: real world cumulative outcomes and treatment trajectories — Filippo Maria Ubaldi, Federica Innocenti, Marilena Taggi et al. Frontiers in Endocrinology, 2026, cohort, 1 citations · DOI: 10.3389/fendo.2026.1854570
  4. In vitro fertilization outcomes in transgender individuals with prior testosterone therapy. — Rubin ES, Kornfield M, Palmor M et al. Human reproduction (Oxford, England), 2026, cohort · DOI: 10.1093/humrep/deag003
  5. Ovarian responsiveness during random-start stimulation and DuoStim in women: comparative insights from domestic animal models — D.R. Bergfelt Frontiers in Endocrinology, 2026, expert opinion · DOI: 10.3389/fendo.2026.1980858
  6. Impact of Endometrial Scratching on IVF/ICSI Outcomes: A Meta-Analysis — Rimantas Gricius, Kamilė Piesliakaitė, Ramunė Narutytė et al. Journal of Clinical Medicine, 2026, systematic review · DOI: 10.3390/jcm15093340
  7. Multi-Site Cortical Puncture for DOR First Affiliated Hospital of Guangxi Medical University, 2026, rct
  8. L26/P-732 A family-building perspective in IVF: the contribution of each additional oocyte to cumulative live birth rate — Erika Pittana, P. Petrone, A. Ruffa et al. Human Reproduction, 2026, cohort · DOI: 10.1093/humrep/deag083.1059
  9. Exploring determinants of cumulative live birth rates in IVF: insights from the EELI study in Lebanon — Kassandra Fares, Emile Roger Whaibeh, Elie Edward Matta et al. Reproductive Health, 2026, cohort · DOI: 10.1186/s12978-025-02253-1
  10. Improving the efficiency of oocyte cryopreservation in veterinary medicine — Penelope Maria Gugole AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna), 2026, unknown · DOI: 10.48676/unibo/amsdottorato/12583
  11. Endometriosis as a risk factor: impact on IVF outcomes and reproductive parameters: a systematic review and meta-analysis — Liting Liao, Zhijian Pan, Yanjuan Li Archives of Gynecology and Obstetrics, 2025, systematic review, 7 citations · DOI: 10.1007/s00404-025-08137-w
  12. DuoStim Shows Comparable Efficacy but Better Efficiency than Two Conventional Stimulations in Poor/Suboptimal Responders Undergoing Vitrified Oocyte Accumulation for PGT-A — Stefano Canosa, Alberto Revelli, Danilo Cimadomo et al. Life, 2025, cohort, 4 citations · DOI: 10.3390/life15060899
  13. From hope to hesitation: why couples fail to return for infertility treatment after the first consultation. — Scognamiglio C, Cirillo F, Ronchetti C et al. Human reproduction (Oxford, England), 2025, cohort, 3 citations · DOI: 10.1093/humrep/deaf012
  14. Improved clinical outcomes with a modified warming protocol in donor oocyte cycles — Chun‐I Lee, Hsiu-Hui Chen, Shu-Hui Lin et al. Journal of Ovarian Research, 2025, cohort, 3 citations · DOI: 10.1186/s13048-025-01776-2
  15. Ovarian stimulation: Cycle essentials for managing a cycle — Gerçek Aydın Istanbul Health and Technology University Institutional Repository, 2025, unknown
  16. Advanced KPI framework for IVF pregnancy prediction models in IVF protocols — Sergei Sergeev, Iuliia Diakova Scientific Reports, 2024, cohort, 10 citations · DOI: 10.1038/s41598-024-80759-7
  17. Oocyte accumulation in low-ovarian reserve women: do or not to do? — Mohamed Elmahdy, Duaa Mohamed, M. T. Shouman Journal of Reproductive Medicine and Embryology, 2024, expert opinion · DOI: 10.21608/jrme.2024.260287.1001
  18. Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. Ginefiv, 2024, rct
  19. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF — Nathalie Massin, Inès Abdennebi, Géraldine Porcu‐Buisson et al. Human Reproduction, 2023, rct, 43 citations · DOI: 10.1093/humrep/dead038
  20. What do women undergoing in vitro fertilization (IVF) understand about their chance of IVF success? — Carine McMahon, Karin Hammarberg, Sarah F. Lensen et al. Human Reproduction, 2023, cross sectional, 19 citations · DOI: 10.1093/humrep/dead239
  21. New insights into the role of LH in early ovarian follicular growth: a possible tool to optimize follicular recruitment — Antonio La Marca, Maria Longo, Giovanna Sighinolfi et al. Reproductive BioMedicine Online, 2023, unknown, 19 citations · DOI: 10.1016/j.rbmo.2023.103369
  22. Factors affecting superovulation induction in goats (Capra hericus): An analysis of various approaches — Samiullah Khan, Muhammad Ameen Jamal, Ibrar Muhammad Khan et al. Frontiers in Veterinary Science, 2023, unknown, 15 citations · DOI: 10.3389/fvets.2023.1152103
  23. Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis — Wenjing Shao, Yuying Li, Yanli Wang Journal of Ovarian Research, 2023, systematic review, 10 citations · DOI: 10.1186/s13048-023-01245-8
  24. Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders Shanghai First Maternity and Infant Hospital, 2023, rct
  25. Female dietary patterns and outcomes of in vitro fertilization (IVF): a systematic literature review — Elizabeth A. Sanderman, Sydney K. Willis, Lauren Anne Wise Nutrition Journal, 2022, systematic review, 42 citations · DOI: 10.1186/s12937-021-00757-7
  26. Presence of adenomyosis at MRI reduces live birth rates in ART cycles for endometriosis. — Bourdon M, Santulli P, Bordonne C et al. Human reproduction (Oxford, England), 2022, cohort, 28 citations · DOI: 10.1093/humrep/deac083
  27. Effectiveness and Cost-effectiveness of Minimal Ovarian Stimulation in-vitro Fertilization versus Conventional Ovarian Stimulation in Poor Responders: Economic Evaluation Alongside a Propensity Score Adjusted Prospective Observational Study — Tatiane Oliveira de Souza, Ângela Jornada Ben, Johanna Maria van Dongen et al. JBRA, 2022, cohort, 6 citations · DOI: 10.5935/1518-0557.20220025
  28. Mathematical modelling of follicular growth and ovarian stimulation — Sophie Fischer-Holzhausen, Susanna Röblitz Current Opinion in Endocrine and Metabolic Research, 2022, systematic review, 5 citations · DOI: 10.1016/j.coemr.2022.100385
  29. O-072 Can preimplantation genetic testing for monogenic conditions represent an indication for DuoStim? A multicenter case series — Elisabetta Trabucco, Alberto Vaiarelli, Danilo Cimadomo et al. Human Reproduction, 2022, case series, 1 citations · DOI: 10.1093/humrep/deac104.086
  30. Cumulative live birth rate after IVF: trend over time and the impact of blastocyst culture and vitrification — Z Saket, Karin Källén, Kersti Lundin et al. Human Reproduction Open, 2021, registry, 53 citations · DOI: 10.1093/hropen/hoab021
  31. The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility — Yixuan Wu, Haiying Liu, Jianqiao Liu Frontiers in Endocrinology, 2021, cohort, 12 citations · DOI: 10.3389/fendo.2021.768975
  32. Comparison of Cumulative Live Birth Rates Per Aspiration IVF/ICSI Cycle Between GnRH Antagonist Protocol and Progesterone-Primed Ovarian Stimulation Protocol for Infertility With Normal Ovarian Reserve: A Randomised Controlled Trial — Hongjuan Ye, Xue Xue, Liya Shi et al. Research Square, 2021, rct, 1 citations · DOI: 10.21203/rs.3.rs-927208/v1
  33. Cumulative pregnancy and live birth rates following intrauterine insemination and in vitro fertilization in couples with unexplained infertility — Nejc Kozar, Borut Kovačič, Milan Reljič et al. Acta Medico-Biotechnica, 2021, cohort · DOI: 10.18690/actabiomed.186
  34. Ovarian stimulation for freeze-all IVF cycles: a systematic review — Yossi Mizrachi, Eran Horowitz, Jacob Farhi et al. Human Reproduction Update, 2019, systematic review, 106 citations · DOI: 10.1093/humupd/dmz037
  35. Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle — Wen Ding, Fuli Zhang, Xiaocong Liu et al. Frontiers in Endocrinology, 2019, cohort, 41 citations · DOI: 10.3389/fendo.2019.00516
  36. Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient — Sandro Cassiano Esteves, Matheus Roque, Sesh Kamal Sunkara et al. Human Reproduction, 2019, unknown, 28 citations · DOI: 10.1093/humrep/dez181
  37. Effect of GnRH analogues for pituitary suppression on oocyte morphology in repeated ovarian stimulation cycles — Bianca Ferrarini Zanetti, Daniela Paes de Almeida Ferreira Braga, Amanda Souza Setti et al. JBRA, 2019, cohort, 16 citations · DOI: 10.5935/1518-0557.20190050
  38. Impact of Maternal Age on Oocyte and Embryo Competence. — Cimadomo D, Fabozzi G, Vaiarelli A et al. Frontiers in endocrinology, 2018, expert opinion, 472 citations · DOI: 10.3389/fendo.2018.00327
  39. Endometrial scratching prior to IVF; does it help and for whom? A systematic review and meta-analysis — Nienke E. van Hoogenhuijze, Jenneke C. Kasius, Frank J. Broekmans et al. Human Reproduction Open, 2018, systematic review, 75 citations · DOI: 10.1093/hropen/hoy025
  40. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women — Le Dang Khoa, Lan N. Vuong, Tuong Manh Ho et al. Human Reproduction, 2018, rct, 62 citations · DOI: 10.1093/humrep/dey253
  41. Methodological approaches to analyzing IVF data with multiple cycles — Jennifer J. Yland, Carmen Messerlian, Lidia Mínguez‐Alarcón et al. Human Reproduction, 2018, cohort, 44 citations · DOI: 10.1093/humrep/dey374
  42. Risks and complications associated with ovarian stimulation for fertility treatment — Miriam N. Baumgarten Nottingham ePrints (University of Nottingham), 2018, unknown
  43. Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders Centre Hospitalier Intercommunal Creteil, 2018, rct
  44. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles — Monique H. Mochtar, Nora A. Danhof, Reuben Olugbenga Ayeleke et al. Cochrane Database of Systematic Reviews, 2017, systematic review, 115 citations · DOI: 10.1002/14651858.cd005070.pub3
  45. Poster Presentations — Alice Fatet, Lydie Nadal‐Desbarats, Karine Boissard et al. Reproduction in Domestic Animals, 2017, animal, 4 citations · DOI: 10.1111/rda.13026
  46. DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore IVI Madrid, 2017, rct
  47. Cumulative live birth rate: time for a consensus? — Abha Maheshwari, David J. McLernon, Siladitya Bhattacharya Human Reproduction, 2015, expert opinion, 301 citations · DOI: 10.1093/humrep/dev263
  48. Association between intrafollicular concentration of benzene and outcome of controlled ovarian stimulation in IVF/ICSI cycles: a pilot study — Carlo Alviggi, Rossella Guadagni, Alessandro Conforti et al. Journal of Ovarian Research, 2014, cohort, 53 citations · DOI: 10.1186/1757-2215-7-67
  49. Effects of ovarian stimulation on oocyte development and embryo quality — Kimberley Marie Swann Nottingham ePrints (University of Nottingham), 2014, animal, 1 citations
  50. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice — Antonio La Marca, Sesh Kamal Sunkara Human Reproduction Update, 2013, systematic review, 587 citations · DOI: 10.1093/humupd/dmt037
  51. Differences in quality of life and emotional status between infertile women and their partners. — Huppelschoten AG, van Dongen AJ, Verhaak CM et al. Human reproduction (Oxford, England), 2013, cross sectional, 83 citations · DOI: 10.1093/humrep/det239
  52. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios. — Groen H, Tonch N, Simons AH et al. Human reproduction (Oxford, England), 2013, cohort, 36 citations · DOI: 10.1093/humrep/det386
  53. Predicting IVF outcome — L.L. van Loendersloot UvA-DARE (University of Amsterdam), 2013, unknown
  54. The optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis — Xiru Liu, Hua-Qiao Mu, Qi Shi et al. Reproductive Biology and Endocrinology, 2012, systematic review, 59 citations · DOI: 10.1186/1477-7827-10-107
  55. Oral Progestin Priming Increases Ovarian Sensitivity to Gonadotropin Stimulation and Improves Luteal Function in the Cat1 — Rosemary A. Stewart, Katharine M. Pelican, Adrienne E. Crosier et al. Biology of Reproduction, 2012, unknown, 41 citations · DOI: 10.1095/biolreprod.112.104190
  56. Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece. — Fragoulakis V, Kourlaba G, Tarlatzis B et al. ClinicoEconomics and outcomes research : CEOR, 2012, unknown, 8 citations · DOI: 10.2147/ceor.s31972
  57. ART, clinical: ovarian stimulation Human Reproduction, 2009, unknown, 1 citations · DOI: 10.1093/humrep/dep775
  58. Mild ovarian stimulation for IVF — M.F.G. Verberg, Nick Macklon, Geeta Nargund et al. Human Reproduction Update, 2008, expert opinion, 195 citations · DOI: 10.1093/humupd/dmn056
  59. Regulation of follicular wave pattern in cattle — R.S. Jaiswal University Library - University of Saskatchewan (University of Saskatchewan), 2007, unknown, 5 citations
  60. The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization — Nick Macklon, Richard L. Stouffer, Linda C. Giudice et al. Endocrine Reviews, 2006, systematic review, 562 citations · DOI: 10.1210/er.2005-0015
  61. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation. — Bedaiwy MA, Forman R, Mousa NA et al. Human reproduction (Oxford, England), 2006, unknown, 46 citations · DOI: 10.1093/humrep/del273
  62. Effects of subfertility cause, smoking and body weight on the success rate of IVF — A.M.E. Lintsen, Pieternel C. M. Pasker-de Jong, Evelien J. de Boer et al. Human Reproduction, 2005, cohort, 253 citations · DOI: 10.1093/humrep/deh898
  63. ART/Ovarian stimulation 2 (O-108-113) Human Reproduction, 2003, case report · DOI: 10.1093/oxfordjournals.humrep.a002192
  64. Eighteenth UICC International Cancer Conference June 30–July 5, 2002 — PA Abrahamsen International Journal of Cancer, 2002, in vitro, 1 citations · DOI: 10.1002/ijc.10523
  65. Maturation of human oocytes in vitro and their developmental competence — Alan O. Trounson, Cleola Anderiesz, G Jones Reproduction, 2001, expert opinion, 378 citations · DOI: 10.1530/rep.0.1210051
  66. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. — Nargund G, Waterstone J, Bland J et al. Human reproduction (Oxford, England), 2001, cohort, 204 citations · DOI: 10.1093/humrep/16.2.259
  67. In Vivo Embryogenesis, Embryo Migration, and Embryonic Mortality in the Domestic Cat1 — William Frederick Swanson, Terri L. Roth, David E. Wildt Biology of Reproduction, 1994, unknown, 93 citations · DOI: 10.1095/biolreprod51.3.452